General Information
Drug ID
DR00132
Drug Name
Phosphate
Synonyms
14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V)
Drug Type
Small molecular drug
Indication Constipation [ICD11: ME05.0] Approved [1]
Structure
3D MOL 2D MOL
Formula
O4P-3
Canonical SMILES
[O-]P(=O)([O-])[O-]
InChI
InChI=1S/H3O4P/c1-5(2,3)4/h(H3,1,2,3,4)/p-3
InChIKey
NBIIXXVUZAFLBC-UHFFFAOYSA-K
CAS Number
CAS 14265-44-2
Pharmaceutical Properties Molecular Weight 94.971 Topological Polar Surface Area 86.2
Heavy Atom Count 5 Rotatable Bond Count 0
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 4
XLogP
-2.3
PubChem CID
1061
PubChem SID
103066731 , 103077071 , 104042950 , 104075345 , 104296651 , 125331104 , 125823182 , 126524047 , 134989311 , 135292823 , 137001640 , 142051012 , 14709385 , 152043015 , 15218698 , 163304750 , 175268694 , 176264609 , 176270178 , 223741247 , 24439414 , 3071 , 53787703 , 56310835 , 56311388 , 57320705 , 7728230 , 7889982 , 79295108 , 8144764 , 8150953 , 840917 , 841057
ChEBI ID
CHEBI:18367
TTD Drug ID
D08VYC
DT(s) Transporting This Drug DIC Transporter Info Mitochondrial dicarboxylate carrier Substrate [2]
G3PP Transporter Info Glycerol-3-phosphate permease Substrate [3]
NPT1 Transporter Info Sodium-dependent phosphate transport protein 1 Substrate [4]
NPT4 Transporter Info Sodium-dependent phosphate transport protein 4 Substrate [5]
PHC Transporter Info Phosphate carrier protein Substrate [6]
PIT1 Transporter Info Sodium-dependent phosphate transporter 1 Substrate [7]
PIT2 Transporter Info Sodium-dependent phosphate transporter 2 Substrate [7]
SCAMC1 Transporter Info Calcium-binding mitochondrial carrier protein SCaMC-1 Substrate [8]
SCAMC2 Transporter Info Calcium-binding mitochondrial carrier protein SCaMC-2 Substrate [9]
SCAMC3 Transporter Info Calcium-binding mitochondrial carrier protein SCaMC-3 Substrate [10]
SLC17A4 Transporter Info Probable small intestine urate exporter Substrate [11]
VGLUT1 Transporter Info Vesicular glutamate transporter 1 Substrate [12]
VGLUT2 Transporter Info Vesicular glutamate transporter 2 Substrate [4]
References
1 Phosphate was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 SLC25A10 biallelic mutations in intractable epileptic encephalopathy with complex I deficiency. Hum Mol Genet. 2018 Feb 1;27(3):499-504.
3 SLC37A1 and SLC37A2 are phosphate-linked, glucose-6-phosphate antiporters. PLoS One. 2011;6(9):e23157.
4 Type 1 sodium-dependent phosphate transporter (SLC17A1 Protein) is a Cl(-)-dependent urate exporter. J Biol Chem. 2010 Aug 20;285(34):26107-13.
5 Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate. J Biol Chem. 2010 Nov 5;285(45):35123-32.
6 The mammalian phosphate carrier SLC25A3 is a mitochondrial copper transporter required for cytochrome c oxidase biogenesis. J Biol Chem. 2018 Feb 9;293(6):1887-1896.
7 Phosphate transporters and their function. Annu Rev Physiol. 2013;75:535-50.
8 De Novo Mutations in SLC25A24 Cause a Disorder Characterized by Early Aging, Bone Dysplasia, Characteristic Face, and Early Demise. Am J Hum Genet. 2017 Nov 2;101(5):844-855.
9 Ketogenic diet induces expression of the muscle circadian gene Slc25a25 via neural pathway that might be involved in muscle thermogenesis. Sci Rep. 2017 Jun 6;7(1):2885.
10 Cellular expression and alternative splicing of SLC25A23, a member of the mitochondrial Ca2+-dependent solute carrier gene family. Gene. 2005 Jan 31;345(2):173-82.
11 A Na+-phosphate cotransporter homologue (SLC17A4 protein) is an intestinal organic anion exporter. Am J Physiol Cell Physiol. 2012 Jun 1;302(11):C1652-60.
12 SLC17: a functionally diverse family of organic anion transporters. Mol Aspects Med. 2013 Apr-Jun;34(2-3):350-9.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.